Citations

Mayo Clinic

Clear

504 citation(s) found for "Palmer, S M".

A phase I/II study of ixazomib (Ix) pomalidomide (POM) dexamethasone (DEX) in relapsed refractory (R/R) multiple myeloma: Initial results.
Krishnan, Amrita , Kapoor, Prashant , Kumar, Shaji , Htut, Myo , Karanes, Chatchada , Rosenzweig, Michael , Sahebi, Firoozeh , Somlo, George, Duarte, Lupe, Forman, Stephen J. , Palmer, Joycelynne Michelle , Lonial, Sagar , Nathwani, Nitya , Berdeja, Jesús G.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8008-8008

10.1200/jco.2016.34.15_suppl.8008 Get It

Choosing a reduced intensity conditioning, fludarabine melphalan versus fludarabine busulfan: A meta-analysis and systematic review.
Jain, Tania , Firwana, Belal , Almader‐Douglas, Diana , Palmer, Jeanne , Jain, Tania , Sonbol, Mohamad Bassam

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e19017-e19017

10.1200/jco.2018.36.15_suppl.e19017 Get It

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802
Holtan, Shernan G. , Khera, Nandita , Levine, John E. , Lee, Stephanie J. , Inamoto, Yoshihiro , Mayer, Sebastian , Arora, Mukta , Palmer, Jeanne , Arai, Sally , Lazaryan, Aleksandr , Newell, Laura F. , Jagasia, Madan , Pusic, Iskra , Wood, William A. , Renteria, Anne S. , Yanik, Gregory A. , Ayuk, Francis , Holler, Ernst , Bunworasate, Udomsak , Efebera, Yvonne A. , Ferrara, James L.M. , Pidala, Joseph, Howard, Alan , Wu, Juan , Bolaños‐Meade, Javier , Ho, Vincent T. , Alousi, Amin, Weisdorf, Daniel J. , MacMillan, Margaret L. , Weisdorf, Dan , Levine, John E , Holtan, Shernan , DeFor, Todd E. , Panoskaltsis‐Mortari, Angela , Flowers, Mary E.D. , Chen, George L. , Cutler, Corey S. , Hogan, William J. , Hexner, Elizabeth O. , Howard, Alan, Alousi, Amin Majid , Blazar, Bruce R. , Lee, Stephanie J , Wood, William A

Blood Advances | August 28, 2018 | Volume: 2 | Issue: 15 | Pages: 1882-1888

10.1182/bloodadvances.2018017343 | PMID 30087106 Get It

Key PointsHigh-circulating AREG (≥33 pg/mL) reclassifies additional patients into HR categories and further refines the Minnesota aGVHD risk score. Patients with aGVHD and AREG ≥33 pg/mL have lower rates of steroid response, higher NRM, and poorer OS.
Effectiveness of Electroconvulsive Therapy in Patients With Major Depressive Disorder and Comorbid Borderline Personality Disorder
Lee, James H. , Kung, Simon , Rasmussen, Keith G., Palmer, Brian A.

The Journal of ECT | August 16, 2018 | Volume: 35 | Issue: 1 | Pages: 44-47

10.1097/yct.0000000000000533 | PMID 30113988 Get It

Objective Previous research suggests that electroconvulsive therapy (ECT)—the criterion standard for the treatment of severe depression—is not as effective when the patient has comorbid borderline personality disorder (BPD). The ECT outcomes of patients with and without BPD were compared in a retrospective chart review to test this claim. Methods We enrolled 137 patients with a diagnosis of major depressive disorder who completed the McLean Screening Instrument for Borderline Personality Disorder. Twenty-nine patients had positive screening scores for BPD. The difference in Patient Health Questionnaire (PHQ-9) scores before and after ECT was compared between patients with and without BPD. Follow-up PHQ-9 scores determined after treatment were collected and analyzed. Results Electroconvulsive therapy equally improved symptoms of depression as measured by PHQ-9 score in both patients who screened positive and patients who screened negative for BPD. No difference in the increase in PHQ-9 scores between these 2 groups was noted 1 month after treatment (P = 0.19). Conclusions These data showed that a positive BPD screen does not necessarily predict a poorer response to ECT, nor does it predict greater symptom recurrence after ECT. This does not suggest that ECT is necessarily an appropriate treatment for major depressive disorder in patients with a comorbid BPD, given the limitations of screening instruments.
Exome Chip Analysis Identifies Low-Frequency and Rare Variants in MRPL38 for White Matter Hyperintensities on Brain Magnetic Resonance Imaging
Jian, Xueqiu , Satizábal, Claudia L. , Smith, Albert V. , Wittfeld, Katharina , Bis, Joshua C. , Smith, Jennifer A. , Hofer, Edith , Mishra, Aniket , Adams, Hieab H.H. , Li, Shuo , Teumer, Alexander , Zhao, Wei , Saba, Yasaman , Yanek, Lisa R. , Chauhan, Ganesh , Buchem, Mark A. van , Royle, Natalie A., Niessen, Wiro J. , Windham, B. Gwen , DeStefano, Anita L. , Habes, Mohamad , Heckbert, Susan R. , Palmer, Nicholette D., Lewis, Cora E. , Eiríksdóttir, Guðný , Maillard, Pauline , Mathias, Rasika A. , Divers, Jasmin, Beiser, Alexa S., Langner, Sönke , Rice, Kenneth , Bastin, Mark E. , Starr, John M. , Sidney, Stephen , Risacher, Shannon L. , Uitterlinden, André G. , Guðnason, Vilmundur , Rotter, Jerome I. , Schreiner, Pamela J. , Boerwinkle, Eric , Duijn, Cornelia M. van , Sarnowski, Bettina von , Gottesman, Rebecca F., Levy, Daniel , Sigurðsson, Sigurður , Vernooij, Meike W. , Schmidt, Reinhold, Wardlaw, Joanna M. , Mosley, Thomas H. , DeCarli, Charles , Bowden, Donald W. , Becker, Diane M. , Deary, Ian J. , Schmidt, Helena , Kardia, Sharon L. R., Debette, Stéphanie , Longstreth, W.T. , Seshadri, Sudha , Launer, Lenore J. , Fornage, Myriam , Group, for the neuroCHARGE Working, Dichgans, Martin , Rice, Kenneth , Palmer, Nicholette D. , DeCarli, Charles , Turner, Stephen T. , Dichgans, Martin , Wardlaw, Joanna Marguerite , Smith, Jennifer A , Adams, Hieab H H , Satizabal, Claudia L , Seshadri, Sudha , Bastin, Mark E , Teumer, Alexander , van Duijn, Cornelia M , Debette, Stephanie , Smith, Albert V , Palmer, Nicholette D , Rotter, Jerome I , Mathias, Rasika A , Rice, Ken , Levy, Daniel , Hsu, Fang‐Chi , Nho, Kwangsik T. , Hagenaars, Saskia P. , Nyquist, Paul , Freedman, Barry I. , Cushman, Mary , Bryan, Robert Nick , Homuth, Georg , Hernández, Maria del Carmen Valdés , Divers, Jasmin , Yang, Qiong , Maldjian, Joseph A. , Nauck, Matthias A. , Mazoyer, Bernard , Psaty, Bruce M. , Saykin, Andrew J. , Ikram, M. Arfan , Grabe, Hans Jörgen , Group, for the neuroCHARGE Working, Maillard, Pauline

Stroke | July 12, 2018 | Volume: 49 | Issue: 8 | Pages: 1812-1819

10.1161/strokeaha.118.020689 | PMID 30002152 Get It

Background and Purpose— White matter hyperintensities (WMH) on brain magnetic resonance imaging are typical signs of cerebral small vessel disease and may indicate various preclinical, age-related neurological disorders, such as stroke. Though WMH are highly heritable, known common variants explain a small proportion of the WMH variance. The contribution of low-frequency/rare coding variants to WMH burden has not been explored. Methods— In the discovery sample we recruited 20 719 stroke/dementia-free adults from 13 population-based cohort studies within the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium, among which 17 790 were of European ancestry and 2929 of African ancestry. We genotyped these participants at ≈250 000 mostly exonic variants with Illumina HumanExome BeadChip arrays. We performed ethnicity-specific linear regression on rank-normalized WMH in each study separately, which were then combined in meta-analyses to test for association with single variants and genes aggregating the effects of putatively functional low-frequency/rare variants. We then sought replication of the top findings in 1192 adults (European ancestry) with whole exome/genome sequencing data from 2 independent studies. Results— At 17q25, we confirmed the association of multiple common variants in TRIM65 , FBF1 , and ACOX1 ( P <6×10 −7 ). We also identified a novel association with 2 low-frequency nonsynonymous variants in MRPL38 (lead, rs34136221; P EA =4.5×10 −8 ) partially independent of known common signal ( P EA(conditional) =1.4×10 −3 ). We further identified a locus at 2q33 containing common variants in NBEAL1 , CARF , and WDR12 (lead, rs2351524; P all =1.9×10 −10 ). Although our novel findings were not replicated because of limited power and possible differences in study design, meta-analysis of the discovery and replication samples yielded stronger association for the 2 low-frequency MRPL38 variants ( P rs34136221 =2.8×10 −8 ). Conclusions— Both common and low-frequency/rare functional variants influence WMH. Larger replication and experimental follow-up are essential to confirm our findings and uncover the biological causal mechanisms of age-related WMH.
Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation
Jain, Tania , Grys, Thomas E. , Kung, Shu Ting, Shah, Vishal , Betcher, Jeffrey, Slack, James L., Leis, José F., Khera, Nandita , Noël, Pierre, Palmer, Jeanne , Sproat, Lisa Z., Shah, Vishal S, Betcher, Jeffrey A, Palmer, Jeanne M., Jain, Tania , Kosiorek, Heidi , Shah, Vishal , Grys, Thomas E

Leukemia & Lymphoma | July 6, 2018 | Volume: 60 | Issue: 1 | Pages: 110-117

10.1080/10428194.2018.1459603 | PMID 29979906 Get It

Goniotomy Using the Kahook Dual Blade in Severe and Refractory Glaucoma: 6-Month Outcomes
Salinas, Lauriane, Chaudhary, Ankita, Lazcano-Gómez, Gabriel , Williamson, Blake K. , Dorairaj, Syril , Seibold, Leonard K., Smith, Sanjay, Aref, Ahmad A. , Darlington, Jason K., Jiménez-Román, Jesús, Mahootchi, Ahad , Boucékine, Mohamed , Mansouri, Kaweh , Dorairaj, Syril K., Berdahl, John Palmer

Journal of Glaucoma | July 4, 2018 | Volume: 27 | Issue: 10 | Pages: 849-855

10.1097/ijg.0000000000001019 | PMID 29979337 Get It

Purpose: The purpose of the study is to describe short-term efficacy and safety of goniotomy with trabecular meshwork excision using the Kahook Dual Blade (KDB, New World Medical Inc., Rancho Cucamonga, CA) in patients with severe or refractory glaucoma. Method: Retrospective multicentric case series of 53 eyes with severe or refractory glaucoma as defined by ICD-10 conducted in the United States, Mexico, and Switzerland. Primary efficacy outcome was a ≥20% decrease in intraocular pressure (IOP) from baseline at 6 months. Secondary efficacy outcome measures were probability of achieving an IOP≤14 or 18 mm Hg at 6 months and the mean IOP change from baseline at 6 months. Medication use required to obtain target IOP at last follow up and adverse effects were analyzed. Results: The proportion of eyes achieving an IOP reduction of >20% from preoperative baseline at 6 months was 57.7% (n=30). The mean IOP decreased from 18.4±6.1 mm Hg at baseline to 13.9±3.5 mm Hg at month 6 (23.9% reduction; P<0.001). At 6 months, 63.5% and 92.3% achieved an IOP≤14 and ≤18 mm Hg, respectively, and the mean number of glaucoma medications was reduced by 1.2±1.3 (36.6%) compared with baseline (P<0.001). The most common adverse event was hyphema (n=29, 34.9%) with spontaneous resolution in all cases. No severe complications were reported. One case presented with uncontrolled IOP and required glaucoma drainage device surgery at 1 month. Conclusions: Goniotomy with trabecular meshwork excision using the KDB could be an alternative surgery for severe or refractory glaucoma, significantly reducing IOP and medication use at 6 months, with a low rate of complications.
Association of Total Fluid Intake and Output with Duration of Hospital Stay in Patients with Acute Pancreatitis
Koop, Andree , Jackson, Jillian K., Henry, April, Horsley‐Silva, Jennifer L. , Pannala, Rahul , Heckman, Michael G. , Diehl, Nancy N. , Palmer, William C. , Koop, Andree H , Stancampiano, Fernando F , Jackson, Jillian, Horsley-Silva, Jennifer, Heckman, Michael G , Diehl, Nancy N , Palmer, William C , Stancampiano, Fernando F.

Gastroenterology Research and Practice | May 2, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-8

10.1155/2018/7614381 | PMID 29853865 Get It

Background/Aims. The aim of this study was to evaluate the association of fluid balance with outcomes in patients hospitalized with acute pancreatitis (AP).Methods. This was a retrospective study of patients hospitalized between May 2008 and June 2016 with AP and a clinical order for strict recording of intake and output. Data collected included various types of fluid intake and output at 24 and 48 hours after admission. The primary outcome was length of stay (LOS). Analysis was performed using single-variable and multivariable negative binomial regression models.Results. Of 1256 patients hospitalized for AP during the study period, only 71 patients (5.6%) had a clinical order for strict recording of intake and output. Increased urine output was associated with a decreased LOS at 24 and 48 hours in univariable analysis. An increasingly positive fluid balance (total intake minus urine output) at 24 hours was associated with a longer LOS in multivariable analysis.Conclusions. Few patients hospitalized for AP had a documented order for strict monitoring of fluid intake and output, despite the importance of monitoring fluid balance in these patients. Our study suggests an association between urine output and fluid balance with LOS in AP.
A cross-sectional study of learning styles among continuing medical education participants
Collins, C. Scott, Nanda, S. , Palmer, Brian A. , Mohabbat, Arya B. , Schleck, Cathy D. , Mandrekar, Jayawant N. , Mahapatra, Saswati , Beckman, Thomas J. , Wittich, Christopher M. , Nanda, Sanjeev

Medical Teacher | April 28, 2018 | Volume: 41 | Issue: 3 | Pages: 318-324

10.1080/0142159x.2018.1464134 | PMID 29703093 Get It